Ind-Swift Laboratories is currently trading at Rs. 91.20, up by 4.30 points or 4.95% from its previous closing of Rs. 86.90 on the BSE.
The scrip opened at Rs. 90.00 and has touched a high and low of Rs. 91.20 and Rs. 88.10 respectively. So far 158173 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 91.20 on 15-Jun-2018 and a 52 week low of Rs. 31.00 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 91.20 and Rs. 72.35 respectively. The current market cap of the company is Rs. 429.34 crore.
The promoters holding in the company stood at 54.80%, while Institutions and Non-Institutions held 0.77% and 44.43% respectively.
Ind-Swift Laboratories has raised Rs 424.5 crore through the allotment of 4245 Secured Rated Listed Redeemable Non Convertible Debentures (NCDs) of face value of Rs 10,00,000 each to investors whose bids are accepted through EBP Mechanism. The date of Allotment is June 13, 2018 and interest/ coupon rate is 10%. The tenure of allotment is 6 years. The Board of Directors in their meeting held on June 13, 2018, approved the same.
Ind-Swift Laboratories has manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1515.25 |
Dr. Reddys Lab | 6241.60 |
Cipla | 1480.95 |
Zydus Lifesciences | 1063.45 |
Lupin | 1584.30 |
View more.. |